Literature DB >> 21107677

Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis.

Yeong-Gon Choi1, Sujung Yeo, Yeon-Mi Hong, Sabina Lim.   

Abstract

Acupuncture at acupoints GB34 and LR3 has been reported to inhibit nigrostriatal degeneration in Parkinsonism models, yet the genes related to this preventive effect of acupuncture on the nigrostriatal dopaminergic system remain elusive. This study investigated gene expression profile changes in the striatal region of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism models after acupuncture at the acupoints GB34 and LR3 using a whole transcript genechip microarray (Affymetrix genechip mouse gene 1.0 ST array). It was confirmed that acupuncture at these acupoints could inhibit the decrease of tyrosine hydroxylase and dopamine transporter in the nigrostriatal region of the MPTP model while acupuncture at the non-acupoints could not counteract this decrease. Genechip gene array analysis (fold change cutoff 1.3 and P < 0.05) showed that 12 of the 69 probes up-regulated in MPTP when compared to the control were down-regulated by acupuncture at the acupoints. Of these 12 probes, 11 probes (nine annotated genes) were exclusively down-regulated by acupuncture only at the acupoints; the Gfral gene was excluded because it was commonly down-regulated by acupuncture at both the acupoints and the non-acupoints. In addition, 28 of the 189 probes down-regulated in MPTP when compared to the control were up-regulated by acupuncture at the acupoints. Of these 28 probes, 19 probes (seven annotated genes) were exclusively up-regulated by acupuncture only at the acupoints while nine probes were commonly up-regulated by acupuncture at both the acupoints and the non-acupoints. The regulation patterns of representative genes in real-time RT-PCR correlated with those of the genes in the microarray. These results suggest that the 30 probes (16 annotated genes), which are affected by MPTP and acupuncture only at the acupoints, are responsible for exerting in the striatal regions the inhibitory effect of acupuncture at the acupoints on MPTP-induced striatal degeneration.

Entities:  

Mesh:

Year:  2010        PMID: 21107677     DOI: 10.1007/s10571-010-9629-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  71 in total

Review 1.  Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs.

Authors:  Silvia Mandel; Orly Weinreb; Moussa B H Youdim
Journal:  Trends Pharmacol Sci       Date:  2003-04       Impact factor: 14.819

2.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.

Authors:  Francesco Fornai; Oliver M Schlüter; Paola Lenzi; Marco Gesi; Riccardo Ruffoli; Michela Ferrucci; Gloria Lazzeri; Carla L Busceti; Fabrizio Pontarelli; Giuseppe Battaglia; Antonio Pellegrini; Ferdinando Nicoletti; Stefano Ruggieri; Antonio Paparelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

Review 3.  Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

4.  N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.

Authors:  Yeong-Gon Choi; Sabina Lim
Journal:  Biochimie       Date:  2010-07-17       Impact factor: 4.079

5.  Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40.

Authors:  Alexander M Simon; Andrea R McWhorter
Journal:  Dev Biol       Date:  2002-11-15       Impact factor: 3.582

6.  Effect of aging on neuroglobin expression in rodent brain.

Authors:  Yunjuan Sun; Kunlin Jin; Xiao Ou Mao; Lin Xie; Alyson Peel; Jocelyn T Childs; Anna Logvinova; Xiaojuan Wang; David A Greenberg
Journal:  Neurobiol Aging       Date:  2005-02       Impact factor: 4.673

7.  Mammary tumor induction in transgenic mice expressing an RNA-binding protein.

Authors:  Charles R Tessier; Glenn A Doyle; Brad A Clark; Henry C Pitot; Jeff Ross
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

8.  Expression of connexins in embryonic mouse neocortical development.

Authors:  Cima Cina; John F Bechberger; Mark A Ozog; Christian C G Naus
Journal:  J Comp Neurol       Date:  2007-09-20       Impact factor: 3.215

9.  Early effects of FGF-2 on glial cells in the MPTP-lesioned striatum.

Authors:  S B Wirth; M Rufer; K Unsicker
Journal:  Exp Neurol       Date:  1996-02       Impact factor: 5.330

10.  Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model.

Authors:  Mee Sook Hong; Hun-Kuk Park; Jong-Soo Yang; Hi-Joon Park; Seung-Tae Kim; Seung-Nam Kim; Ji-Yeun Park; Jeong Yoon Song; Hyun-Kyung Park; Dae Jean Jo; Sung Wook Park; Dong HwanYun; Ju Yeon Ban; Joo-Ho Chung
Journal:  Neurol Res       Date:  2010-02       Impact factor: 2.448

View more
  14 in total

Review 1.  Traditional Chinese medicine for modern treatment of Parkinson's disease.

Authors:  Lu Han; Yuan-Hong Xie; Rong Wu; Chen Chen; Yan Zhang; Xiao-Ping Wang
Journal:  Chin J Integr Med       Date:  2017-01-20       Impact factor: 1.978

Review 2.  Complementary Medicine Therapies That May Assist With Weight Loss: A Narrative Review.

Authors:  Brett R Martin
Journal:  J Chiropr Med       Date:  2019-07-02

3.  Neuroprotective changes in degeneration-related gene expression in the substantia nigra following acupuncture in an MPTP mouse model of Parkinsonism: Microarray analysis.

Authors:  Sujung Yeo; Keon Sang An; Yeon-Mi Hong; Yeong-Gon Choi; Bruce Rosen; Sung-Hoon Kim; Sabina Lim
Journal:  Genet Mol Biol       Date:  2014-03-17       Impact factor: 1.771

4.  Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model.

Authors:  Jiahui Deng; E Lv; Jian Yang; Xiaoli Gong; Wenzhong Zhang; Xibin Liang; Jiazeng Wang; Jun Jia; Xiaomin Wang
Journal:  J Neuroinflammation       Date:  2015-05-28       Impact factor: 8.322

Review 5.  The neuroprotective role of acupuncture and activation of the BDNF signaling pathway.

Authors:  Dong Lin; Ike De La Pena; Lili Lin; Shu-Feng Zhou; Cesar V Borlongan; Chuanhai Cao
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

6.  Systems biology of meridians, acupoints, and chinese herbs in disease.

Authors:  Li-Ling Lin; Ya-Hui Wang; Chi-Yu Lai; Chan-Lao Chau; Guan-Chin Su; Chun-Yi Yang; Shu-Ying Lou; Szu-Kai Chen; Kuan-Hao Hsu; Yen-Ling Lai; Wei-Ming Wu; Jian-Long Huang; Chih-Hsin Liao; Hsueh-Fen Juan
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-18       Impact factor: 2.629

7.  The holistic effects of acupuncture treatment.

Authors:  Jing-Wen Yang; Qian-Qian Li; Fang Li; Qing-Nan Fu; Xiang-Hong Zeng; Cun-Zhi Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-12       Impact factor: 2.629

8.  Gene Expression Profiles at Moxibustioned Site (ST36): A Microarray Analysis.

Authors:  Hai-Yan Yin; Yong Tang; Sheng-Feng Lu; Ling Luo; Jia-Ping Wang; Xu-Guang Liu; Shu-Guang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-22       Impact factor: 2.629

Review 9.  Understanding Acupuncture Based on ZHENG Classification from System Perspective.

Authors:  Junwei Fang; Ningning Zheng; Yang Wang; Huijuan Cao; Shujun Sun; Jianye Dai; Qianhua Li; Yongyu Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-21       Impact factor: 2.629

10.  Acupuncture on GB34 activates the precentral gyrus and prefrontal cortex in Parkinson's disease.

Authors:  Sujung Yeo; Il-Hwan Choe; Maurits van den Noort; Peggy Bosch; Geon-Ho Jahng; Bruce Rosen; Sung-Hoon Kim; Sabina Lim
Journal:  BMC Complement Altern Med       Date:  2014-09-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.